Biocon Company Profile

21:25 EDT 18th March 2018 | BioPortfolio

Biocon is India's leading biotechnology enterprise. Over the past 25 years, we have evolved from an enzyme manufacturing company to a fully integrated biopharmaceutical enterprise, focused on healthcare. We apply our proprietary fermentation technologies to develop innovative and effective biomolecules in diabetology, oncology, cardiology and other therapeutic segments. At Biocon, our success has been our ability to develop innovative technologies and products and to rapidly leverage them to adjacent domains. This unique "integrated innovation" approach has yielded a host of patented products and technologies that have enabled multi-level relationships with our global clientele.


1406, Woodbridge Commons
New Jersey
United States of America


Phone: 732 636 2950
Fax: 732 636 2951

News Articles [79 Associated News Articles listed on BioPortfolio]

Biocon's Biosimilar Arm May Raise $500M to Fund Clinical Development

Biotechnology major BioCon is likely to take its group entity Biocon Biologics public and is expected to raise about $500M.

Mylan and Biocon biosimilar approval expands to Brazil

Since Mylan and Biocon managed to gain US FDA approval for its Herceptin (Trastuzumab) biosimilar, it has forged ahead in the global market to make up for time lost due to manufacturing issues. It has...

Biocon’s Avastin Biosimilar To Put The Heat On Competition?

Biocon has launched its biosimilar Avastin in India, intensifying competition on the market. In addition to its ‘affordable’ price, Biocon’s...  

Biocon, Dr Reddy’s Might Be Out Of The Woods On GMP Issue

Two Indian firms – Biocon and Dr Reddy’s – have received crucial establishment inspection reports (EIRs) from the US FDA...  

Mylan and Biocon Neulasta biosimilar knocked back by FDA

Mylan and Biocon’s biosimilar version of Amgen’s blockbuster, Neulasta (pegfilgrastim), will have to wait a bit longer before getting the nod from the FDA, after receiving a CRL related manufactur...

Biocon says FDA 483 at Malaysian plant not due to non-compliance

A US FDA pre-approval inspection of Bioconâs insulin manufacturing facility in Malaysia has resulted in a Form 483 with six observations.

Mylan, Biocon's biosims back on track in EU after manufacturing snag

In August, Biocon had withdrawn two applications for approval of proposed biosimilars after the EMA said it would need to reinspect a drug facility.

FDA approves Mylan/Biocon Herceptin biosimilar

The FDA has approved Mylan and Biocon’s biosimilar of Roche’s Herceptin (trastuzumab) breast cancer drug after a delay because of manufacturing issues. The FDA had previously rejected the biosimi...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [6 Associated Companies listed on BioPortfolio]

Biocon Limited

Established in 1978, Biocon Limited is India's largest biotechnology Company by revenue. The Group, promoted by Ms. Kiran Mazumdar-Shaw, is a fully-integrated, innovation-driven h...

BioCon Valley® GmbH

Born out of Germany´s "BioRegio" competition in 1996 BioCon Valley represents an interdisciplinary network in the field of modern life sciences and health care.Universities, research and health care ...


Biocon is India's leading biotechnology enterprise. Over the past 25 years, we have evolved from an enzyme manufacturing company to a fully integrated biopharmaceutical enterprise, focused on healthca...


Since 1978 BIOCON has provided highly reliable, custom small animal research services to the region’s leading biomedical scientists. Whether your study involves small animal housing, breeding and co...

Biocon Ltd

More Information about "Biocon" on BioPortfolio

We have published hundreds of Biocon news stories on BioPortfolio along with dozens of Biocon Clinical Trials and PubMed Articles about Biocon for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biocon Companies in our database. You can also find out about relevant Biocon Drugs and Medications on this site too.

Quick Search


Relevant Topics

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into different molecules, called products. Almost all chemical re...

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Corporate Database Quicklinks

Searches Linking to this Company Record